Maham Afridi

Maham Afridi

Auto-generated profile, based on publicly available information

Maham Afridi

Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
HAHashaam Akhtar
Hashaam Akhtar
MAMaham Afridi
Maham Afridi
SASamar Akhtar
Samar Akhtar
HAHamaad Ahmad
Hamaad Ahmad
SASabahat Ali
Sabahat Ali
Yousef KhaderYousef Khader
Yousef Khader
The COVID-19 outbreak started as pneumonia in December 2019 in Wuhan, China. The subsequent pandemic was declared as the sixth public health emergency of international concern on January 30, 2020, by the World Health Organization. Pakistan could be a potential hotspot for COVID-19 owing to its high population of 204.65 million and its struggling health care and economic systems. Pakistan was able to tackle the challenge with relatively mild repercussions. The present analysis has been conducted to highlight the situation of the disease in Pakistan in 2020 and the measures taken by various stakeholders coupled with support from the community to abate the risk of catastrophic spread of the virus.

14 December 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
HAHashaam Akhtar
Hashaam Akhtar
SKSundas Khalid
Sundas Khalid
FRFazal Ur Rahman
Fazal Ur Rahman
MUMuhammad Umar
Muhammad Umar
SASabahat Ali
Sabahat Ali
Aamer IkramAamer Ikram
Aamer Ikram
Background: COVID-19 became a pandemic rapidly after its emergence in December 2019. It belongs to the coronavirus family of viruses, which have struck a few times before in history. Data based on previous research regarding etiology and epidemiology of other viruses from this family helped played a vital role in formulating prevention and precaution strategies during the initial stages of this pandemic. Data related to COVID-19 in Pakistan were not initially documented on a large scale. In addition, due to a weak health care system and low economic conditions, Pakistan’s population, in general, already suffers from many comorbidities, which can severely affect the outcome of patients infected with COVID-19. Objective: COVID-19 infections are coupled with a manifestation of various notable outcomes that can be documented and characterized clinically. The aim of this study was to examine these clinical manifestations, which can serve as indicators for early detection as well as severity prognosis for COVID-19 infections, especially in high-risk groups. Methods: A retrospective observational study involving abstraction of demographic features, presenting symptoms, and adverse clinical outcomes for 1812 patients with COVID-19 was conducted. Patients were admitted to the four major hospitals in the Rawalpindi-Islamabad region of Pakistan, and the study was conducted from February to August 2020. Multivariate regression analysis was carried out to identify significant indicators of COVID-19 severity, intensive care unit (ICU) admission, ventilator aid, and mortality. The study not only relates COVID-19 infection with comorbidities, but also examines other related factors, such as age and gender. Results: This study identified fever (1592/1812, 87.9%), cough (1433/1812, 79.1%), and shortness of breath (998/1812, 55.1%) at the time of hospital admission as the most prevalent symptoms for patients with COVID-19. These symptoms were common but not conclusive of the outcome of infection. Out of 1812 patients, 24.4% (n=443) required ICU admission and 21.5% (n=390) required ventilator aid at some point of disease progression during their stay at the hospital; 25.9% (n=469) of the patients died. Further analysis revealed the relationship of the presented symptoms and comorbidities with the progression of disease severity in these patients. Older adult patients with comorbidities, such as hypertension, diabetes, chronic kidney disease, and asthma, were significantly affected in higher proportions, resulting in requirement of ICU admission and ventilator aid in some cases and, in many cases, even mortality. Conclusions: Older adult patients with comorbidities, such as hypertension, diabetes, asthma, chronic obstructive pulmonary disorder, and chronic kidney disease, are at increased risk of developing severe COVID-19 infections, with an increased likelihood of adverse clinical outcomes.

27 May 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
HAHashaam Akhtar
Hashaam Akhtar
SASamar Akhtar
Samar Akhtar
FRFazal-Ul Rahman
Fazal-Ul Rahman
MAMaham Afridi
Maham Afridi
SKSundas Khalid
Sundas Khalid
MKMuhammad Mujeeb Khan
Muhammad Mujeeb Khan
Background: Since the first reports of COVID-19 infection, the foremost requirement has been to identify a treatment regimen that not only fights the causative agent but also controls the associated complications of the infection. Due to the time-consuming process of drug discovery, physicians have used readily available drugs and therapies for treatment of infections to minimize the death toll. Objective: The aim of this study is to provide a snapshot analysis of the major drugs used in a cohort of 1562 Pakistani patients during the period from May to July 2020, when the first wave of COVID-19 peaked in Pakistan. Methods: A retrospective observational study was performed to provide an overview of the major drugs used in a cohort of 1562 patients with COVID-19 admitted to the four major tertiary-care hospitals in the Rawalpindi-Islamabad region of Pakistan during the peak of the first wave of COVID-19 in the country (May-July 2020). Results: Antibiotics were the most common choice out of all the therapies employed, and they were used as first line of treatment for COVID-19. Azithromycin was the most prescribed drug for treatment. No monthly trend was observed in the choice of antibiotics, and these drugs appeared to be a random but favored choice throughout the months of the study. It was also noted that even antibiotics used for multidrug resistant infections were prescribed irrespective of the severity or progression of the infection. The results of the analysis are alarming, as this approach may lead to antibiotic resistance and complications in immunocompromised patients with COVID-19. A total of 1562 patients (1064 male, 68.1%, and 498 female, 31.9%) with a mean age of 47.35 years (SD 17.03) were included in the study. The highest frequency of patient hospitalizations occurred in June (846/1562, 54.2%). Conclusions: Guidelines for a targeted treatment regime are needed to control related complications and to limit the misuse of antibiotics in the management of COVID-19.

19 May 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
SASabahat Ali
Sabahat Ali
SKSundas Khalid
Sundas Khalid
MAMaham Afridi
Maham Afridi
SASamar Akhtar
Samar Akhtar
Yousef KhaderYousef Khader
Yousef Khader
HAHashaam Akhtar
Hashaam Akhtar
SARS-CoV-2 is known to cause severe bilateral pneumonia and acute respiratory distress syndrome or COVID-19 in patients, which can be debilitating and even fatal. With no drugs or vaccines available yet, a wide range of treatment regimens used are being repurposed. The need of the hour is to analyze various currently available regimens and devise a treatment plan that is most effective for COVID-19. Here we describe the case of a 68-year-old man with hypertension and diabetes, exhibiting symptoms of cough and shortness of breath, who presented at the emergency department of our hospital. Chest computed tomography revealed bilateral ground glass opacities that were indicative of COVID-19, and a computed tomography score of 24 was indicative of severe pulmonary pneumonia. He tested positive for COVID-19. His treatment regimen included the use of convalescent plasma, oxygen therapy, steroids, high-dose antibiotics, broad-spectrum antiviral remdesivir, and anti–interleukin-6 monoclonal antibody (Tocilizumab) at various stages of the disease. Oxygen supplementation was required at the time of admission. The patient initially developed a cytokine release storm, and oxygen supplementation was initiated to manage his condition. Supportive care and multiple treatment regimens were used to successfully recover the patient’s health. With a rapid increase in number of confirmed cases worldwide, COVID-19 has become a major challenge to our health care system. With no available vaccines currently, the establishment of a combination of therapeutic drugs that effectively reduce disease progression is of utmost importance.

30 January 2021 in JMIR Preprints
Verified
Preprint
Open access
USUmar Shahzad
Umar Shahzad
HSHufsa Shahzad
Hufsa Shahzad
NANaveed Anwer
Naveed Anwer
MAMaham Afridi
Maham Afridi
Yousef KhaderYousef Khader
Yousef Khader
HAHashaam Akhtar
Hashaam Akhtar
BACKGROUND COVID-19 Lockdown has limited the non-essential movement of people. Consequently, the effects of lockdown had a remarkable impact on everyday life, including health, social sector, economic decline, supply chain sectors and education sector. Just because the social distancing is in ascend, people are looking up new ways to connect and Smart Phones are the most convenient, accessible, and cost-effective way to stay connected during this pandemic. People have become significantly dependent on their smart phones during COVID-19 pandemic that allow to work from home and stay connected with the world. Smartphone addiction is known as nomophobia (NMP) which is a fear of not using smart phone. OBJECTIVE This nondrug addiction is as dangerous as drug addiction. It produces behavioral modifications in everyday habits and actions. Much research is available on nomophobia, to the best of author’s knowledge, there is no literature available on the prevalence of NMP during COVID-19 lockdown METHODS It was a descriptive cross-sectional study. Subjects fulfilling the selection criteria were enrolled in the study through public sector universities of Islamabad and Rawalpindi. Non- Probability convenient sampling technique was used to select 580 students of both genders from 18 to 24 years of age. 18 Students who were corona positive or having any known psychiatric disorder were excluded from the study. A cross sectional survey was conducted online by via Google form. Validated Nomophobia Questionnaire (NMP-Q) was utilized. A self-reported questionnaire regarding demographic data and information regarding use of smart phone. It is the most widely used measurement instrument, proposed by Yildrim and Correia, anyone can use it for noncommercial research and educational projects. NMP-Q includes 20 Likert scale items rated from 1 strongly disagree to 7 strongly agree. The lowest score on the NMP-Q is 20 and 140 is the highest. 20 represent absent of nomophobia, 21 – 59 mild level, 60 – 99 moderate level and 100 – 140 severe nomophobia. Google forms automatically analyzed the collected data. RESULTS A total of 580 subjects 290 (50%) were male and 290 (50%) were female. Mean age was 21 ± 2.3 years. Out of 580 subjects 460(79.31%) were nomophobic. Subject who had severe nomophobia were 19%, moderate nomophobia 58% and mild nomophobia 23%. Subject reported that they could not stay away from their smart phones and keep their phones with them even at bedtime. 226 (38.9%) subjects never turned their phone off. 253 (43.6%) subjects carry a power bank with them so they may not run out of battery. Out of 290 female students 199 (68.6%) were nomophobic and out of 290 male subjects 261 (90%) were nomophobic. So, nomophobia was more prevalent in male. Most frequent reason for using smart phone was social networking (WhatsApp, Facebook, twitter, Instagram, tiktok, snapchat) 91% and playing games 73%. CONCLUSIONS High prevalence of nomophobia was found. Due to COVID -19 lockdown students have straight off become dependent on smart phones that allow them to work and learn from home and take online classes. Smart phone is only source of entertainment for them so there is a huge percentage of a student having moderate nomophobia. So time of using smart phones should be regularized in order to avoid serious harmful effects due to prolong use.

5 March 2021 in JMIR Preprints
Verified
Preprint
Open access
HAHashaam Akhtar
Hashaam Akhtar
MAMaham Afridi
Maham Afridi
SASamar Akhtar
Samar Akhtar
HAHamaad Ahmad
Hamaad Ahmad
SASabahat Ali
Sabahat Ali
Yousef KhaderYousef Khader
Yousef Khader
UNSTRUCTURED The COVID-19 outbreak started as pneumonia in December 2019 in Wuhan, China. The subsequent pandemic was declared as the sixth public health emergency of international concern on January 30, 2020, by the World Health Organization. Pakistan could be a potential hotspot for COVID-19 owing to its high population of 204.65 million and its struggling health care and economic systems. Pakistan was able to tackle the challenge with relatively mild repercussions. The present analysis has been conducted to highlight the situation of the disease in Pakistan in 2020 and the measures taken by various stakeholders coupled with support from the community to abate the risk of catastrophic spread of the virus.